Advertisement
Advertisement
SER
Serina Therapeutics, Inc.
1.43
USDSponsored
0.00
0.00%
Nov 10, 15:59 UTC -5
Closed
After-Market
1.41
-0.02
-1.40%
Serina Therapeutics, Inc. (SER)
Serina Therapeutics, Inc. Financial Snapshot
| Market Cap | 35.81M |
| Beta | 1.29 |
| Earnings Per Share (EPS) | -1.89 |
| Price-to-Book (P/B) Ratio | 2.29 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 16.48% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -416.40% |
| Current Ratio | 6.65% |
| Free Cash Flow | -11.30M |
